4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-25-090431
Chief Legal Officer sold 11,491 shares at $6.80 ($78,139)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Sullivan Mark · Chief Legal Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-25 | Sale : show line 1 in the form 10b5-1 | −11,491 | $6.80 | $78,139 | 305,130 | D |
| Open-market sales · 11,491 sh · avg $6.80 · $78,139 | ||||||
Loading xslF345X05/ownership.xml…